MYO1E and focal segmental glomerulosclerosis: The behavior of the abnormal Myo1e protein also provides a hint as to why agents that stabilize the podocyte cytoskeleton (e.g., cyclosporine) are important to the successful therapy of focal segmental glomerulosclerosis [27].